Glucosamine market

Glucosamine Market, by Product Type (Powder, Tablets , Capsules, and Liquid), by Application (Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Request Free Sample

Dec 2020
CMI4345
160 Pages
Excel & Pdf
Pharmaceutical

Summary

Glucosamine is an amino sugar and one of the most commonly produced mono-saccharides synthetically by the hydrolysis of shellfish exoskeleton or fermentation process of grains such as wheat and corn. There are various medicinal uses of synthetic glucosamine. For instance, oral glucosamine is used as a dietary supplement for various health conditions such as joint pain and arthritis. Most commonly marketed preparation of glucosamine include glucosamine sulfate, glucosamine chondroitin, glucosamine hydrochloride, and N-acetylglucosamine. Glucosamine is commonly used with chondroitin for the treatment of symptomatic osteoarthritis of the knee in the individuals.

The global glucosamine market is estimated to be valued at US$ 763.7 million in 2020 and is expected to exhibit a CAGR of 5.20% during the forecast period (2020-2027).

Figure 1. Global Glucosamine Market Value (US$ Mn), 2016-2027

The increasing prevalence of rheumatoid arthritis is expected to propel growth of the global glucosamine market during the forecast period. For instance, according to the US National Library of Medicine’s report published in 2017, prevalence of rheumatoid arthritis across the globe was 43.3 % in 2017.

Furthermore, key players are focusing on launch and approval of product which is expected to propel growth of the global glucosamine market during the forecast period. For instance, in 2016, TSI Group Co. Ltd. (TSI) launched GlucosaGreenDF, a novel non-shellfish glucosamine branded product line produced by a patent-pending direct fermentation technology, in compliance with international monographs such as USP and the European Pharmacopeia.

Glucosamine Market Report Coverage

Report Coverage	Details
Base Year:	2019	Market Size in 2020:	US$ 763.7 Mn
Historical Data for:	2016 to 2019	Forecast Period:	2020 to 2027
Forecast Period 2020 to 2027 CAGR:	5.20 %	2027 Value Projection:	US$ 1,091.2 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC, Israel, and Rest of the Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Powder, Tablets, Capsules, Liquid. By Application: Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Others. By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Companies covered:	Bio-gen Extracts Private Limited, Panvo Organics Pvt Ltd, Pharma Base S.A., CAPTEK Softgel International Inc., TSI Health Sciences, Inc., Cargill, CellMark Chemicals, Andra Medi Pharma Pvt. Ltd, Zhejiang Zhoushan Putuo Xinxing Pharmas Co., Ltd. (PXPC), JIAXING HENGJIE BIOPHARMACEUTICAL CO.,LTD. , Wellable Marine Biotech Holding Limited, Zhejiang Shinfuda Marine Biotechnology Corp, Spectrum Chemical Manufacturing Corporation and Atlina Life Sciences, Schiff Nutrition International, Inc. and Golden-Shell Pharmaceutical Co. Ltd.
Growth Drivers:	The increasing prevalence of rheumatoid arthritis, asthma across the globe Focus of key players on research and development in the field of glucosamine
Restraints & Challenges:	The various side effects associated with glucosamine such as heartburn, drowsiness, and headache

Global Glucosamine Market – Impact of Coronavirus (COVID-19)

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, manifestation of coronavirus (COVID-19) has resulted in more than 72.3 million infected individuals worldwide as of 14^th December, 2020.

Furthermore, COVID-19 has affected almost every market across the world and has also impacted the global glucosamine market in the following ways: by directly affecting the production and demand; by creating disruptions in distribution channels; and by its financial impact on firms and financial markets. Supply chain and manufacturing activities in India, China, and the U.S. have been disrupted due to nationwide lockdowns. Whereas, countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of drugs from one place to another.

Figure 2. Global Glucosamine Market Share (%), By Region, 2020

North America is expected to hold dominant position in the global glucosamine market during the forecast period owing to research and development activities in the field of glucosamine. For instance, in August 2018, Carlson Lab launched a novel formulation of Carlson Glucosamine & Chondroitin with Methyl SulfonylMethane (MSM), which provides human bone nourishing nutrients in one supplement.

Key Players

Major players operating in the global glucosamine market are Bio-gen Extracts Private Limited, Panvo Organics Pvt Ltd, Pharma Base S.A., CAPTEK Softgel International Inc., TSI Health Sciences, Inc., Cargill, CellMark Chemicals, Andra Medi Pharma Pvt. Ltd, Zhejiang Zhoushan Putuo Xinxing Pharmas Co., Ltd. (PXPC), JIAXING HENGJIE BIOPHARMACEUTICAL CO.,LTD. , Wellable Marine Biotech Holding Limited, Zhejiang Shinfuda Marine Biotechnology Corp, Spectrum Chemical Manufacturing Corporation and Atlina Life Sciences, Schiff Nutrition International, Inc., and Golden-Shell Pharmaceutical Co. Ltd.

Table of Content

*Browse 28 market data tables and 32 figures on " Glucosamine Market – Global forecast to 2027”.

N/A

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the market during the forecast period (2020-2027)?

The global glucosamine market size is estimated to be valued at US$ 763.7 million in 2020 and is expected to exhibit a CAGR of 5.20% between 2020 and 2027.

What are the major factors driving the growth of the global glucosamine market?

The increasing prevalence of health conditions such as rheumatoid arthritis, asthma cross the globe, and research and development by key players operating in the glucosamine market are driving the market growth.

Which is the leading product type segment in the global glucosamine market?

The powder segment is estimated to hold major market share in the global glucosamine market during the forecast period owing to launch of glucosamine products indicated for the treatment of diseases such as rheumatoid arthritis.

Which is the leading segment on the basis of application in the global glucosamine market?

The rheumatoid arthritis segment is estimated to hold major share in the global glucosamine market during the forecast period owing to the increasing prevalence of rheumatoid arthritis globally.

Which region is estimated to generate the largest market share in 2020 in the global glucosamine market?

North America is estimated to generate the largest revenue share in 2020 in the global glucosamine market.

What are the key factors hampering growth of the market?

The side effects associated with glucosamine such as heartburn, drowsiness, and headache are expected to hamper growth of the market.